摘要:
A failure detection system detects a failure of a package in a redundant system having a duplex package configuration. The failure detection system includes a first package including a signal processor for carrying out a predetermined signal processing on an input signal to the first package, where the first package is provided in each of first and second systems, a second package including a selector for selectively outputting an output signal of the signal processor of the first package in one of the first and second systems in response to a control signal, a failure detector for detecting a failure in the output signal of the signal processor of the first package in each of the first and second systems and for outputting a failure detection signal if the failure is detected, and a signal processor for carrying out a predetermined signal processing on the output signal of the selector, where the second package is provided in each of first and second systems, and a controller for supplying the control signal to the selector of the second package in each of the first and second systems based on the failure detection signal received from the second package in each of the first and second systems, so that the selector selectively outputs the output signal of the signal processor of the first package in an active one of the first and second systems. The controller includes a mechanism for disregarding the failure detection signal received from the second package during a predetermined time in response to a predetermined signal. This predetermined signal may indicate which one of the first and second systems is active or, indicate whether or not the second package of each of the first and second systems is mounted on a unit to which the first package of each of the first and second systems is mounted.
摘要:
A clock distribution system includes a clock generation and distribution part for generating a clock signal and distributing the generated clock signal to a plurality of destinations, slots in each of which a clock reception unit can be detachably mounted, and a plurality of transmission lines coupling the clock generation and distribution part to the slots. Each slot includes a circuit for generating a mount state signal which indicates whether or not the slot is mounted with a clock reception unit, and for supplying the mount state signal to the clock generation and distribution part via a transmission line. This mount state signal has a first state when no clock receiving unit is mounted in the slot and has a second state when a clock receiving unit is mounted in the slot. The clock generation and distribution part includes a circuit for receiving the mount state signal from each slot and for transmitting via the transmission line the clock signal to each slot from which a mount state signal having the second state is received.
摘要:
The present invention provides a biological substance detection method for specifically detecting a biological substance from a pathological specimen, by which method, when immunostaining using a fluorescent label and staining for morphological observation using a staining agent for morphological observation are simultaneously performed, the results of fluorescence observation and immunostaining can be assessed properly even if the fluorescent label and/or the staining agent is/are deteriorated by irradiation with an excitation light. The biological substance detection method according to the present invention is characterized in that the brightness retention rate of an immunostained part is in a range of 80% to 120% in relation to the brightness retention rate of apart stained for morphological observation when the fluorescent label used for the immunostaining is observed.
摘要:
A highly accurate and quantitative method for determining cancer onset or cancer onset risk by a quantitative tissue staining method in biological tissues using an antibody capable of recognizing a cancer growth regulatory factor or cancer metastasis regulatory factor such as PAR1 antibody, which inhibits the cancer cell mobility and infiltration is provided. Cancer onset or cancer onset risk is determined using the tissue staining method comprising the steps of: labeling an antibody which recognizes a cancer growth regulatory factor or cancer metastasis regulatory factor with a fluorescent material, and contacting the fluorescent-labeled antibody with a tissue sample; irradiating a tissue site in contact with the antibody with excitation light to acquire a fluorescence image; acquiring an autofluorescence image in a vicinity region of a short wavelength side or long wavelength side of an acquisition region of fluorescence wavelength emitted by the fluorescent material, in the same field of vision and in the same focal point as those of the fluorescence image; acquiring a corrected fluorescence image by image processing to eliminate a fluorescent brightness of the autofluorescence image from the fluorescent brightness of the fluorescence image; counting the number of cells at the tissue site in contact with the antibody; measuring a mean fluorescent brightness of a single fluorescent particle; and calculating the number of fluorescent particles per cell.
摘要:
A tissue staining method which comprises: staining a tissue with a staining reagent wherein a biosubstance recognition site is bonded to particles carrying multiple fluorescent substances accumulated therein; in the stained tissue, counting fluorescent points or measuring fluorescent brightness; and evaluating the expression level of a biosubstance, which matches the biosubstance recognition site, in the aforesaid tissue on the basis of the number of the fluorescent points or fluorescent brightness that was measured.
摘要:
It is an object of the present invention to provide a tissue staining method that makes it possible to observe both information on the morphology of a tissue and information on a biological substance such as an antigen molecule to be detected on a single section and in a single view field. The present invention provides a tissue staining method, including carrying out (A) a HE (hematoxylin-eosin) staining, and (B) a histochemical staining, serially on a single tissue section, wherein the histochemical staining is defined as a histochemical technique for detecting a biological substance to be detected in a tissue in a visible manner by use of a binding reaction between the biological substance to be detected and a probe biological substance capable of binding specifically to the biological substance to be detected.
摘要:
A biological substance detection method for detecting a biological substance specifically in a pathological specimen, comprising a step of immunologically staining the pathological specimen using a fluorescent label, a step of staining the pathological specimen with a staining reagent for morphology observation purposes (eosin) to observe the morphology of the pathological specimen, a step of irradiating the stained pathological specimen, with excited light to cause the emission of a fluorescent and detecting the biological substance in the pathological specimen. In the step of immunologically staining the pathological specimen, a special fluorescent particle for which the excitation wavelength appears in a region that is different from the excitation wavelength region of eosin is used as the fluorescent label.
摘要:
Provided are an antibody which binds specifically PAR1 (protease activated receptor 1) or a fragment of the antibody which retains similar characteristics thereto; a composition containing the same for inhibiting the migration activity and invasion activity of cancer cells; and a medicinal composition for treating cancer and the like.
摘要:
A biological substance detection method for detecting a biological substance specifically in a pathological specimen, comprising a step of immunologically staining the pathological specimen using a fluorescent label, a step of staining the pathological specimen with a staining reagent for morphology observation purposes (eosin) to observe the morphology of the pathological specimen, a step of irradiating the stained pathological specimen with excited light to cause the emission of a fluorescent and detecting the biological substance in the pathological specimen. In the step of immunologically staining the pathological specimen, a special fluorescent particle for which the excitation wavelength appears in a region that is different from the excitation wavelength region of eosin is used as the fluorescent label.
摘要:
A semiconductor nanoparticle assembly including semiconductor nanoparticles having a core/shell structure, and wherein the semiconductor nanoparticles are bonded by means of amide bonds.